Select Page

News Feed

To stay up to date on the latest clinical news and information from Combat Medical please see our news channels below. Please ensure you follow or subscribe to the channels in order to receive regular updates

Nanorobots – the future of surgical oncology? That’s what @alarjosan, consultant surgeon in surgical oncology at the Reina Sofia hospital in Córdoba, suggests – find out more in our upcoming Medical Innovators interview.

#medicalinnovation #cancersurgery #HIVEC #CombatCancer

1n 1883 a light bulb was used for the first time to look inside the bladder. 139 years later, we've got robot-assisted surgery. What do you see as the next leap forward in #cancer surgery? @alarjosan shares his ideas in our forthcomingMedical Innovators interview #CombatCancer

Jonathan Goddard@urology_history

#OnThisDay in 1883, David Newman, of Glasgow, was the first to use an electric light bulb to view the inside of a human bladder @BAUSurology @Uro_News @RSMUrology @rcpsglasgow 2

#HIVEC-HR phase II study (Guerrero-Ramos et al, World J Urol, 2022) comparing outcomes of high-risk NMIBC patients randomised to Combat HIVEC® + MMC or BSG

Time to recurrence with HIVEC 21.5 months vs 16.1 months BCG.

#medicalinnovation #bladdercancer #CombatCancer

From our phase II #HIVEC study, published Jan 17 (World J Urol), which found HIVEC + MMC a real alternative to BCG for NMIBC treatment: “The results of our work are particularly relevant in the current health care environment, in which BCG has limited availability.”

Great results from #HIVEC + MMC vs BCG clinical trial for high-risk NMIBC patients 🙂
Recurrence-free survival at 24 months in intention-to-treat analysis was HIVEC 86.5% vs BCG 71.8%, and HIVEC 95.0% vs BCG 75.1% for per protocol analysis. #bladdercancer

📜 We just published our pilot trial using @CombatCancer BRS MMC-HIVEC vs BCG in HR-NMIBC at @wjurol @SpringerNature
💻 You can download and read it here:
@Daniel_Urologia @AlejandroGoDiaz @brantinman @Gamyi3 @Urologia12

Load More...
English EN Spanish ES